1. Stem Cell Therapy

Category Archives: Stem Cell Therapy

Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India – Video

Posted on by


Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India
Improvement seen in just 6 months after Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Earli...

By: Neurogen Brain and Spine Institute

Read the original here:
Short video of Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma Mumbai India - Video

Short video on Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma Mumbai India – Video

Posted on by


Short video on Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma Mumbai India
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. He ca...

By: Neurogen Brain and Spine Institute

Go here to read the rest:
Short video on Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma Mumbai India - Video

Short video of Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma Mumbai – Video

Posted on by


Short video of Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma Mumbai
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Dee...

By: Neurogen Brain and Spine Institute

Read more here:
Short video of Stem Cell Therapy Treatment for Peripheral Nerve Injury by Dr Alok Sharma Mumbai - Video

Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma – Video

Posted on by


Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma. He is a known case of MD with history of gradual onset of progressive lower extremities...

By: Neurogen Brain and Spine Institute

Original post:
Short video on Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma - Video

Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy – Video

Posted on by


Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy
Improvement seen in just 3 months after Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy...

By: Neurogen Brain and Spine Institute

Read more:
Short video on Stem Cell Therapy Treatment for Duchenne Muscular Dystrophy - Video

Short video on Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma Mumbai – Video

Posted on by


Short video on Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma Mumbai
Improvement seen after Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. His neck and...

By: Neurogen Brain and Spine Institute

Read more here:
Short video on Stem Cell Therapy Treatment for Dopamine Responsive Dystonia by Dr Alok Sharma Mumbai - Video

Short video on Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma Mumbai India – Video

Posted on by


Short video on Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma Mumbai India
Improvement seen in just 5 day after Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Command foll...

By: Neurogen Brain and Spine Institute

Go here to read the rest:
Short video on Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma Mumbai India - Video

Understanding the basics of stem cell therapy (First Part)

Posted on by

HUMAN nature has it that when there is something new, be it related to food, enhancements to ones appearance, and even in ones search for answers and treatments to an illness, one may be most willing to brave and enter that unknown territory.

I had the privilege of meeting a very remarkable woman, diagnosed with the Big C of the liver, who, in her desire to prolong her days, agreed to go through stem cell therapy.

In the course of our conversation, I realized that, patients must be given the correct information, and should be armed with the necessary knowledge of the treatment modalities, including success and failure rates, complications, cost and expectations.

This applies not only to what is new, but, even in the most tested of treatment options, patients have the right to know and understand.

Stem cell therapy is one breakthrough in Medical Science. It shows a lot of promise and potential in treating diseases. Stem cell therapy is an intervention strategy where new adult stem cells are introduced into damaged or diseased tissues, in order to treat the disease or injury.

These cells are present during the early stages of life and have the remarkable potential to develop into many different types of cells, and in many tissues, they serve as an internal repair system: they divide to replace and replenish cells that have been diseased.

Research directed to the benefits and usefulness of stem cells, when introduced to a given person with a given injury or illness like the Big C, Diabetes, baldness, leukemia, to name a few, has given rise to clinics and centers offering such services. There are just a few facts that I would like to touch before we get too excited to try it out:

Our body use different types of tissue-specific stem cells to fit a particular purpose. The bone marrow for example has the capacity to regenerate the blood cells.

Stem cells directed to the brain or the pancreas or liver or any organ for that matter must be specific to that organ in order for it to become effective. It is very unlikely then to think that one needs JUST A SINGLE CELL TYPE to treat a multitude of unrelated diseases that involve different tissues or organs.

Once we understand this basic principle of how the stem cells work in the body, we are freed from the incorrect idea that stem cell therapy is a CURE ALL treatment modality.

More here:
Understanding the basics of stem cell therapy (First Part)

Stem Cell Therapy Orlando Testimonial | Stem Cell Treatments Florida – Video

Posted on by


Stem Cell Therapy Orlando Testimonial | Stem Cell Treatments Florida
One of our patients has had successful results with our new revolutionary stem cell treatment in Orlando at Eterna MD. Please learn more at http://www.eterna...

By: Eterna MD Regenerative Medicine

Read the original here:
Stem Cell Therapy Orlando Testimonial | Stem Cell Treatments Florida - Video

Docs seek stop to expensive, experimental stem cell therapy

Posted on by

By Philip C. Tubeza Philippine Daily Inquirer

MANILA, PhilippinesSaying that doctors were exacting exorbitant fees for what is still experimental medicine, the Philippine College of Physicians (PCP) launched Tuesday an online petition urging the Department of Health (DOH) to put a stop to experimental stem cell therapies in the country.

Human stem cell therapy for unproven indications is proliferating in the Philippines and posing serious safety issues to unknowing Filipinos The Philippine College of Physicians is alarmed by the false claims, misinformation and exorbitant fees for such stem cell treatments, read the petition on http://www.change.org.

The PCP urged the DOH to issue a cease and desist order to all doctors performing such therapies as the Philippine Health Insurance Corp. (PhilHealth) clarified that stem cell therapy was not covered by the governments universal healthcare program.

Cease and desist

We, the undersigned, call on the (DOH) to issue a cease and desist order to all doctors, clinics and hospitals that [offer] human stem cell therapy for unproven indications until scientific evidence to support claims of efficacy and safety are approved by the Food and Drug Administration, it said.

The PCP, the umbrella organization of Internal Medicine specialists in the country, said that transplanting human blood-forming stem cells to treat cancerous and noncancerous diseases of the blood was the most widely accepted clinical application of stem cell therapy.

The effectiveness and safety of human stem cell therapy has yet to be proven for heart, neurologic, skin, rheumatologic and gastrointestinal diseases, diabetes, hypertension, autism, cancer, aging and aesthetics, HIV/AIDS and other conditions, the group said.

Lack of evidence

Despite the lack of solid scientific evidence to support the [application] of human stem cell therapy for these conditions, reports of its use precisely for these conditions being received and exorbitant fees being paid by prominent personalities abound in media, the PCP said.

Originally posted here:
Docs seek stop to expensive, experimental stem cell therapy

FDA hearing on stem cell therapy set on Friday, Aug. 23

Posted on by

By: Jet Villa, InterAksyon.com August 18, 2013 5:02 PM

REUTERS FILE PHOTO

InterAksyon.com The online news portal of TV5

MANILA, Philippines - The Food and Drug Administration (FDA) will conduct on Friday, August 23, a public hearing on the regulation of stem cell therapy in the country.

The FDA said the public hearing is scheduled from 3 p.m. to 5 p,m, at the Audio-Visual Room, 3rd floor, Annex Building, FDA office on Civil Drive in Alabang Muntinlupa.

The purpose of the hearing is to discuss the regulation of stem cell therapy, the stem cell products, and the health facilities that are offering the service in the court, it said.

The FDA also established an online reporting system to document adverse events linked to human cells, tissues, and cellular- and tissue-based products such stem cell therapies acquired in any facility.

The agency said those who experienced any untoward event or side effect or treatment failures after undergoing stem cell procedures can report through FDA website at http://www.fda.gov.ph under eReport and Adverse Drug Reaction, Report section.

E-mails may also be sent toreport@fda.gov.ph.

All consumers are assuredthat all information given will be treated with utmost confidentiality.Contact details are needed in case of a need for follow-up and validation.However, anonymous reports will still be accepted, the FDA added.

More:
FDA hearing on stem cell therapy set on Friday, Aug. 23

BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine …

Posted on by

ALAMEDA, Calif.--(BUSINESS WIRE)--

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, announced that Chief Executive Officer Michael D. West, PhD will give the keynote address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine conference on Monday, August 19, 2013, at 12:15 p.m. EDT in Cleveland, Ohio. Dr. West will discuss the potential use of embryonic mesenchymal progenitor cells, generated using BioTimes PureStemtechnology, in regenerative medicine and will contrast the properties of those cells with adult-derived mesenchymal stem cells. He will also discuss how those cells can be utilized in the search for genes potentially useful in induced tissue regeneration (iTR). The presentation will be available on BioTimes website at http://www.biotimeinc.com/scientific-presentations.

MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine, August 19-21, 2013, is being held at the Cleveland Marriott Downtown at Key Center and is presented by Case Western Reserve University and the National Center for Regenerative Medicine.

About BioTime, Inc

BioTime is a biotechnology company engaged in research and product development in the field of regenerative medicine. Regenerative medicine refers to therapies based on stem cell technology that are designed to rebuild cell and tissue function lost due to degenerative disease or injury. BioTimes focus is on pluripotent stem cell technology based on human embryonic stem (hES) cells and induced pluripotent stem (iPS) cells. hES and iPS cells provide a means of manufacturing every cell type in the human body and therefore show considerable promise for the development of a number of new therapeutic products. BioTimes therapeutic and research products include a wide array of proprietary PureStem progenitors, HyStem hydrogels, culture media, and differentiation kits. BioTime is developing Renevia (a HyStem product) as a biocompatible, implantable hyaluronan and collagen-based matrix for cell delivery in human clinical applications. In addition, BioTime has developed Hextend, a blood plasma volume expander for use in surgery, emergency trauma treatment and other applications. Hextend is manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corporation under exclusive licensing agreements.

BioTime is also developing stem cell and other products for research, therapeutic, and diagnostic use through its subsidiaries:

Additional information about BioTime can be found on the web at http://www.biotimeinc.com.

Forward-Looking Statements

Statements pertaining to future financial and/or operating results, future growth in research, technology, clinical development, and potential opportunities for BioTime and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as will, believes, plans, anticipates, expects, estimates) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, uncertainty in the results of clinical trials or regulatory approvals, need and ability to obtain future capital, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the business of BioTime and its subsidiaries, particularly those mentioned in the cautionary statements found in BioTime's Securities and Exchange Commission filings. BioTime disclaims any intent or obligation to update these forward-looking statements.

To receive ongoing BioTime corporate communications, please click on the following link to join our email alert list: http://news.biotimeinc.com.

Read more from the original source:
BioTime CEO Dr. Michael West to Give Keynote Address at the MSC 2013 Adult Stem Cell Therapy & Regenerative Medicine ...


  1. Stem Cell Therapy